U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511790) titled 'Photobiomodulation on Performance in Female Futsal Athletes' on March 30. Brief Summary: T... और पढ़ें
U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07513181) titled 'Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients ... और पढ़ें
U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07512856) titled 'The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Re... और पढ़ें
U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07512089) titled 'Comparison of PRESBYOND Laser Blended Vision and Conventional Monovision LASIK in Individua... और पढ़ें
U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511504) titled 'Y-90 Radioembolization, Durvalumab, Tremelimumab, and Zanzalintinib for the Treatment of Un... और पढ़ें
U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511647) titled 'A Phase 3 Clinical Study of QL2106 Injection' on March 30. Brief Summary: It is a multicen... और पढ़ें
U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511608) titled 'Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers' o... और पढ़ें
U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07512076) titled 'A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer... और पढ़ें
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... और पढ़ें
Singapore, April 7 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... और पढ़ें